Transcriptome Analysis of Human Bone Regeneration After Using an Anorganic Bovine Bone Graft With or Without a Combination of Polynucleotides and Hyaluronic Acid
1 other identifier
interventional
5
1 country
1
Brief Summary
The goal of this clinical trial is to compare the expression of multiple genes related to bone regeneration in maxillary bone after being grafted with a commonly used biomaterial supplemented or not with a combination of hyaluronic acid and polynucleotides.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2023
CompletedFirst Submitted
Initial submission to the registry
November 25, 2023
CompletedFirst Posted
Study publicly available on registry
December 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedMay 28, 2025
May 1, 2025
2 years
November 25, 2023
May 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Transcriptome analysis
Transcriptome analysis of a sample of the regenerated bone will be performed 6 months after grafting immediately before implant placement
6 months
Secondary Outcomes (1)
Sinus floor height change
6 months
Study Arms (2)
Anorganic bovine bone
ACTIVE COMPARATORMaxillary sinus floor augmentation grafted with anorganic bovine bone
Anorganic bovine bone + polynucleotides and hyaluronic acid
EXPERIMENTALMaxillary sinus floor augmentation grafted with anorganic bovine bone + polynucleotides and hyaluronic acid
Interventions
Maxillary sinus floor augmentation through a lateral window grafted with anorganic bovine bone + polynucleotides and hyaluronic acid
Eligibility Criteria
You may qualify if:
- Partially edentulous patients.
- Kennedy class I in the upper jaw.
- Less than 5 mm of residual crestal bone to the maxillary sinus.
- Need for the replacement of teeth with dental implants.
You may not qualify if:
- Sinus pathology (sinusitis, mucocele, cysts).
- Smokers.
- Previous long-term (\>3 months) use of drugs known to affect bone metabolism, such as bisphosphonates.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Granada
Granada, Granada, 18009, Spain
Related Publications (2)
Galindo-Moreno P, Abril-Garcia D, Carrillo-Galvez AB, Zurita F, Martin-Morales N, O'Valle F, Padial-Molina M. Maxillary sinus floor augmentation comparing bovine versus porcine bone xenografts mixed with autogenous bone graft. A split-mouth randomized controlled trial. Clin Oral Implants Res. 2022 May;33(5):524-536. doi: 10.1111/clr.13912. Epub 2022 Mar 3.
PMID: 35224778BACKGROUNDGalindo-Moreno P, de Buitrago JG, Padial-Molina M, Fernandez-Barbero JE, Ata-Ali J, O Valle F. Histopathological comparison of healing after maxillary sinus augmentation using xenograft mixed with autogenous bone versus allograft mixed with autogenous bone. Clin Oral Implants Res. 2018 Feb;29(2):192-201. doi: 10.1111/clr.13098. Epub 2017 Oct 26.
PMID: 29071736BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 25, 2023
First Posted
December 5, 2023
Study Start
September 4, 2023
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
May 28, 2025
Record last verified: 2025-05